Colorado Dental Board: News


Colorado Prescription Drug Monitoring Program Legislative Update and Training Webinar Recording and Summary/FAQ Document Now Available

In August and September 2022, the Colorado Prescription Drug Monitoring Program (PDMP) hosted three webinars concerning several statutory updates to the Colorado PDMP as well as training and resources regarding registration and use of the Colorado PDMP.  A recording of the August 23rd webinar, copy of the presentation slides, and a Summary and Frequently Asked Questions (FAQ) document are now available at




Recommending Medical Marijuana

Marijuana remains a Schedule I controlled substance under the Federal Controlled Substances Act, and recommendations for medical marijuana are not prescriptions.

Article XVIII, Section 14 of the Colorado Constitution, and Section 25-1.5-106 of the Colorado Revised Statutes authorize qualified physicians and advanced practice practitioners with prescriptive authority to recommend medical marijuana if they determine that the patient suffers from a debilitating or disabling medical condition and might benefit from such use. The recommendation is submitted to the Medical Marijuana Registry with the rest of the patient's application. If all other application information is complete and correct, the patient will be issued a registry identification card. The prescriber's recommendation for medical marijuana cannot be "filled" as a prescription at a pharmacy.

Please review this information for more details about the difference between prescriptions and medical marijuana recommendations.


Dental Board

Dental Anesthesia Committee

Revised Rule Effective June 30, 2021

A revised rule for the Colorado Dental Board went into effect on June 30, 2021. The revisions to Rule 1.30, corrected language in the rule that conflicted with portions of section 12-30-115, C.R.S., in Colorado Senate Bill 20-102 (Concerning required disclosures to patients regarding formal actions based on sexual misconduct).

To view the details of this rulemaking project and track all rule changes, see Tracking Number 2021-00204. The Board encourages all licensees and stakeholders to read the revised Rule 1.30. Please direct any questions to